Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab
Farrukh T. Awan(The Ohio State University), David Lucas(Comprehensive Blood & Cancer Center)
Cited by 69